APA

Barnette M. S., Christensen S. B., Essayan D. M., Grous M., Prabhakar U., Rush J. A., Kagey-Sobotka A. & Torphy T. J. (19980211). SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. : The Journal of pharmacology and experimental therapeutics.

Chicago

Barnette M S, Christensen S B, Essayan D M, Grous M, Prabhakar U, Rush J A, Kagey-Sobotka A and Torphy T J. 19980211. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. : The Journal of pharmacology and experimental therapeutics.

Harvard

Barnette M. S., Christensen S. B., Essayan D. M., Grous M., Prabhakar U., Rush J. A., Kagey-Sobotka A. and Torphy T. J. (19980211). SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. : The Journal of pharmacology and experimental therapeutics.

MLA

Barnette M S, Christensen S B, Essayan D M, Grous M, Prabhakar U, Rush J A, Kagey-Sobotka A and Torphy T J. SB 207499 (Ariflo), a potent and selective second-generation phosphodiesterase 4 inhibitor: in vitro anti-inflammatory actions. : The Journal of pharmacology and experimental therapeutics. 19980211.